Accuray Inc (ARAY.O) Key Developments | Reuters.com
Edition:
United States

Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

5.04USD
28 Jun 2016
Change (% chg)

$0.11 (+2.23%)
Prev Close
$4.93
Open
$4.96
Day's High
$5.07
Day's Low
$4.96
Volume
398,836
Avg. Vol
654,303
52-wk High
$7.54
52-wk Low
$4.80

Latest Key Developments (Source: Significant Developments)

Accuray Inc lowers FY 2015 guidance
Thursday, 30 Apr 2015 04:01pm EDT 

Accuray Inc:Revises FY 2015 total revenue of $375 million to $385 million and adjusted EBITDA of $13 million to $16 million.Says revision is caused primarily by the effects of foreign currency on reported results.FY 2015 revenue of $394 million - Thomson Reuters I/B/E/S.  Full Article

Accuray and Christie InnoMed sign exclusive sales agent agreements for radiation therapy systems in Canada
Thursday, 5 Mar 2015 08:30am EST 

Accuray Inc:Enters into sales agent agreements involving the CyberKnife(®) and TomoTherapy(®) System product portfolios in Canada.Under the terms of these agreements, Christie InnoMed will be the exclusive sales agent for Accuray products in this region.  Full Article

Accuray Inc reaffirms FY 2015 guidance
Tuesday, 27 Jan 2015 04:01pm EST 

Accuray Inc:Reaffirms its financial guidance for FY 2015 and expect total revenue of $390.0 million to $410.0 million and adjusted EBITDA of $18.0 million to $27.0 million.FY 2015 revenue of $393 million - Thomson Reuters I/B/E/S.  Full Article

Accuray Inc reaffirms FY 2015 guidance
Wednesday, 29 Oct 2014 04:04pm EDT 

Accuray Inc:Reaffirms its financial guidance for FY 2015 on total revenue of $390 million to $410 million and adjusted EBITDA of $18 million to $27 million.FY 2015 revenue of $402 million - Thomson Reuters I/B/E/S.  Full Article

Accuray signs radiation therapy solutions contract with Premier Inc
Tuesday, 9 Sep 2014 08:35am EDT 

Accuray Inc:Says it has been awarded a new, three-year group purchasing agreement with Premier, Inc., covering the CyberKnife M6 and TomoTherapy HDA product portfolios.Says the Accuray and Premier partnership brings together two companies committed to driving improved patient care through meaningful technical innovation.  Full Article

Accuray Inc gives FY 2015 guidance in line with analysts' estimates
Thursday, 21 Aug 2014 04:02pm EDT 

Accuray Inc:Expects FY 2015 revenues to be in the range of $390 million to $410 million.Expects FY 2015 adjusted EBITDA to be in the range of $18 million to $27 million.FY 2015 revenue of $398 million and EBITDA of $27 million - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Accuray receives 510(K) FDA clearance for image-guided radiation therapy

* Accuray receives 510(k) FDA clearance for the Radixact image-guided radiation therapy platform and integrated software